» Articles » PMID: 22958539

Sub-optimal Delivery of Intermittent Preventive Treatment for Malaria in Pregnancy in Nigeria: Influence of Provider Factors

Overview
Journal Malar J
Publisher Biomed Central
Specialty Tropical Medicine
Date 2012 Sep 11
PMID 22958539
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The level of access to intermittent preventive treatment for malaria in pregnancy (IPTp) in Nigeria is still low despite relatively high antenatal care coverage in the study area. This paper presents information on provider factors that affect the delivery of IPTp in Nigeria.

Methods: Data were collected from heads of maternal health units of 28 public and six private health facilities offering antenatal care (ANC) services in two districts in Enugu State, south-east Nigeria. Provider knowledge of guidelines for IPTp was assessed with regard to four components: the drug used for IPTp, time of first dose administration, of second dose administration, and the strategy for sulphadoxine-pyrimethamine (SP) administration (directly observed treatment, DOT). Provider practices regarding IPTp and facility-related factors that may explain observations such as availability of SP and water were also examined.

Results: Only five (14.7%) of all 34 providers had correct knowledge of all four recommendations for provision of IPTp. None of them was a private provider. DOT strategy was practiced in only one and six private and public providers respectively. Overall, 22 providers supplied women with SP in the facility and women were allowed to take it at home. The most common reason for doing so amongst public providers was that women were required to come for antenatal care on empty stomachs to enhance the validity of manual fundal height estimation. Two private providers did not think it was necessary to use the DOT strategy because they assumed that women would take their drugs at home. Availability of SP and water in the facility, and concerns about side effects were not considered impediments to delivery of IPTp.

Conclusion: There was low level of knowledge of the guidelines for implementation of IPTp by all providers, especially those in the private sector. This had negative effects such as non-practice of DOT strategy by most of the providers, which can lead to low levels of adherence to IPTp and ineffectiveness of IPTp. Capacity development and regular supportive supervisory visits by programme managers could help improve the provision of IPTp.

Citing Articles

Bangladesh should engage the private sector for malaria elimination by 2030.

McArdle R, Phru C, Hossain M, Alam M, Haldar K Lancet Reg Health Southeast Asia. 2024; 31:100487.

PMID: 39399862 PMC: 11465204. DOI: 10.1016/j.lansea.2024.100487.


Synthesis of Qualitative Evidence on Malaria in Pregnancy, 2005-2022: A Systematic Review.

Cardona-Arias J Trop Med Infect Dis. 2023; 8(4).

PMID: 37104360 PMC: 10145031. DOI: 10.3390/tropicalmed8040235.


Factors influencing intermittent preventive treatment for malaria prevention among pregnant women accessing antenatal care in selected primary health care facilities of Bwari Area Council, Abuja Nigeria.

Peters G, Naidoo M PLoS One. 2022; 17(12):e0277877.

PMID: 36520849 PMC: 9754266. DOI: 10.1371/journal.pone.0277877.


Barriers and facilitators to access and uptake of intermittent preventive treatment with sulfadoxine-pyrimethamine among pregnant women in Nigeria: a scoping review.

Ogba P, Baumann A, Chidwick H, Banfield L, DiLiberto D Malariaworld J. 2022; 13:4.

PMID: 35813271 PMC: 9242533.


Motivators and demotivators to accessing malaria in pregnancy interventions in sub-Saharan Africa: a meta-ethnographic review.

Aberese-Ako M, Doegah P, Acquah E, Magnussen P, Ansah E, Ampofo G Malar J. 2022; 21(1):170.

PMID: 35659232 PMC: 9166609. DOI: 10.1186/s12936-022-04205-7.


References
1.
Hill J, Kazembe P . Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges. Trop Med Int Health. 2006; 11(4):409-18. DOI: 10.1111/j.1365-3156.2006.01585.x. View

2.
Gross K, Alba S, Schellenberg J, Kessy F, Mayumana I, Obrist B . The combined effect of determinants on coverage of intermittent preventive treatment of malaria during pregnancy in the Kilombero Valley, Tanzania. Malar J. 2011; 10:140. PMC: 3126755. DOI: 10.1186/1475-2875-10-140. View

3.
Marchant T, Nathan R, Jones C, Mponda H, Bruce J, Sedekia Y . Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania. Malar J. 2008; 7:260. PMC: 2630326. DOI: 10.1186/1475-2875-7-260. View

4.
Aziken M, Akubuo K, Gharoro E . Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria. Int J Gynaecol Obstet. 2010; 112(1):30-3. DOI: 10.1016/j.ijgo.2010.07.027. View

5.
Ashwood-Smith H, Coombes Y, Kaimila N, Bokosi M, Lungu K . Availability and use of sulphadoxine-pyrimethamine (SP) in pregnancy in Blantyre District: A Safe Motherhood and BIMI Joint Survey. Malawi Med J. 2016; 14(1):8-11. PMC: 3345411. View